1.38
|
1.66e-67
|
GO:0044237
|
cellular metabolic process
|
1.52
|
3.60e-67
|
GO:0019222
|
regulation of metabolic process
|
1.56
|
4.12e-67
|
GO:0031323
|
regulation of cellular metabolic process
|
1.56
|
1.58e-65
|
GO:0080090
|
regulation of primary metabolic process
|
1.36
|
2.71e-64
|
GO:0044238
|
primary metabolic process
|
1.56
|
6.00e-63
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.65
|
9.42e-63
|
GO:0010468
|
regulation of gene expression
|
1.45
|
1.38e-62
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.66
|
1.80e-61
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.64
|
1.20e-59
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.32
|
1.28e-59
|
GO:0008152
|
metabolic process
|
1.60
|
8.28e-57
|
GO:0009889
|
regulation of biosynthetic process
|
1.61
|
1.03e-56
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.40
|
1.60e-56
|
GO:0043170
|
macromolecule metabolic process
|
1.65
|
2.55e-54
|
GO:0051252
|
regulation of RNA metabolic process
|
1.65
|
1.40e-53
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.58
|
2.93e-52
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.58
|
1.38e-51
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.54
|
4.74e-45
|
GO:0048518
|
positive regulation of biological process
|
1.57
|
6.51e-45
|
GO:0048522
|
positive regulation of cellular process
|
1.58
|
9.80e-45
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.50
|
1.05e-44
|
GO:0044249
|
cellular biosynthetic process
|
1.58
|
4.21e-44
|
GO:0009059
|
macromolecule biosynthetic process
|
1.49
|
1.56e-43
|
GO:0009058
|
biosynthetic process
|
1.61
|
2.54e-42
|
GO:0048523
|
negative regulation of cellular process
|
1.47
|
6.79e-42
|
GO:0032502
|
developmental process
|
1.52
|
3.02e-40
|
GO:0048856
|
anatomical structure development
|
1.49
|
4.24e-40
|
GO:0007275
|
multicellular organismal development
|
1.55
|
1.01e-39
|
GO:0048731
|
system development
|
1.55
|
1.42e-39
|
GO:0048519
|
negative regulation of biological process
|
1.66
|
2.03e-39
|
GO:0048513
|
organ development
|
1.48
|
7.65e-37
|
GO:0016043
|
cellular component organization
|
1.63
|
1.34e-36
|
GO:0032774
|
RNA biosynthetic process
|
1.88
|
2.65e-36
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.63
|
3.29e-36
|
GO:0006351
|
transcription, DNA-dependent
|
1.44
|
1.63e-35
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.45
|
7.98e-35
|
GO:0071840
|
cellular component organization or biogenesis
|
1.40
|
1.12e-34
|
GO:0006807
|
nitrogen compound metabolic process
|
1.40
|
1.99e-33
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.46
|
1.47e-32
|
GO:0090304
|
nucleic acid metabolic process
|
1.69
|
3.45e-32
|
GO:0009653
|
anatomical structure morphogenesis
|
1.47
|
1.46e-31
|
GO:0010467
|
gene expression
|
1.14
|
2.09e-31
|
GO:0009987
|
cellular process
|
1.96
|
2.31e-29
|
GO:0010629
|
negative regulation of gene expression
|
1.63
|
1.05e-27
|
GO:0009893
|
positive regulation of metabolic process
|
1.47
|
1.08e-27
|
GO:0016070
|
RNA metabolic process
|
1.49
|
1.69e-27
|
GO:0071842
|
cellular component organization at cellular level
|
1.65
|
3.44e-27
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.72
|
3.65e-27
|
GO:0009892
|
negative regulation of metabolic process
|
1.63
|
1.90e-26
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.90
|
4.46e-26
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.46
|
8.02e-26
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.74
|
1.05e-25
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.73
|
1.18e-25
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.46
|
1.18e-25
|
GO:0044267
|
cellular protein metabolic process
|
1.78
|
1.94e-25
|
GO:0009888
|
tissue development
|
1.85
|
2.57e-25
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.94
|
3.34e-25
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.80
|
4.97e-25
|
GO:0009790
|
embryo development
|
1.86
|
7.84e-25
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.82
|
1.58e-24
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.92
|
1.85e-24
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.65
|
2.55e-24
|
GO:0009966
|
regulation of signal transduction
|
2.27
|
5.76e-24
|
GO:0035295
|
tube development
|
1.48
|
1.41e-23
|
GO:0030154
|
cell differentiation
|
1.77
|
3.88e-23
|
GO:0010628
|
positive regulation of gene expression
|
1.47
|
5.62e-23
|
GO:0048869
|
cellular developmental process
|
1.67
|
1.55e-22
|
GO:0050793
|
regulation of developmental process
|
1.52
|
1.74e-22
|
GO:0006464
|
protein modification process
|
1.73
|
2.22e-22
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.78
|
3.17e-22
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.78
|
6.44e-22
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.38
|
6.71e-22
|
GO:0019538
|
protein metabolic process
|
1.82
|
8.19e-22
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.69
|
8.69e-22
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.68
|
1.91e-21
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.82
|
2.13e-21
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.49
|
4.37e-21
|
GO:0043412
|
macromolecule modification
|
1.93
|
1.74e-20
|
GO:0072358
|
cardiovascular system development
|
1.93
|
1.74e-20
|
GO:0072359
|
circulatory system development
|
1.69
|
1.81e-20
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.70
|
1.98e-20
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.64
|
4.87e-20
|
GO:0010941
|
regulation of cell death
|
1.65
|
1.09e-19
|
GO:0042981
|
regulation of apoptosis
|
1.64
|
1.12e-19
|
GO:0043067
|
regulation of programmed cell death
|
1.73
|
3.53e-19
|
GO:0045595
|
regulation of cell differentiation
|
1.91
|
4.25e-19
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.48
|
5.76e-19
|
GO:0048583
|
regulation of response to stimulus
|
1.91
|
1.00e-18
|
GO:0043009
|
chordate embryonic development
|
1.64
|
1.02e-18
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.99
|
1.25e-18
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.66
|
1.30e-18
|
GO:0042127
|
regulation of cell proliferation
|
2.01
|
1.93e-18
|
GO:0032583
|
regulation of gene-specific transcription
|
1.50
|
7.14e-18
|
GO:0006996
|
organelle organization
|
1.82
|
1.03e-17
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.50
|
1.83e-17
|
GO:0023051
|
regulation of signaling
|
1.98
|
2.10e-17
|
GO:0060429
|
epithelium development
|
1.85
|
3.79e-17
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.91
|
5.37e-17
|
GO:0051726
|
regulation of cell cycle
|
2.05
|
1.18e-16
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.53
|
4.06e-16
|
GO:0007399
|
nervous system development
|
1.75
|
5.34e-16
|
GO:0009887
|
organ morphogenesis
|
1.30
|
1.24e-15
|
GO:0051179
|
localization
|
1.96
|
2.62e-15
|
GO:0048729
|
tissue morphogenesis
|
1.61
|
2.86e-15
|
GO:2000026
|
regulation of multicellular organismal development
|
1.64
|
2.92e-15
|
GO:0007049
|
cell cycle
|
2.59
|
3.40e-15
|
GO:0060541
|
respiratory system development
|
2.23
|
8.08e-15
|
GO:0035239
|
tube morphogenesis
|
1.54
|
1.33e-14
|
GO:0010646
|
regulation of cell communication
|
1.14
|
1.65e-14
|
GO:0065007
|
biological regulation
|
1.54
|
2.23e-14
|
GO:0051246
|
regulation of protein metabolic process
|
1.15
|
2.75e-14
|
GO:0050789
|
regulation of biological process
|
2.63
|
3.11e-14
|
GO:0030323
|
respiratory tube development
|
1.50
|
3.89e-14
|
GO:0033036
|
macromolecule localization
|
1.99
|
4.51e-14
|
GO:0001944
|
vasculature development
|
1.15
|
4.61e-14
|
GO:0050794
|
regulation of cellular process
|
2.64
|
4.62e-14
|
GO:0030324
|
lung development
|
1.84
|
1.97e-13
|
GO:0048598
|
embryonic morphogenesis
|
1.58
|
2.76e-13
|
GO:0048468
|
cell development
|
2.04
|
3.18e-13
|
GO:0002009
|
morphogenesis of an epithelium
|
1.53
|
3.85e-13
|
GO:0006796
|
phosphate metabolic process
|
1.53
|
5.34e-13
|
GO:0006793
|
phosphorus metabolic process
|
1.98
|
1.10e-12
|
GO:0001701
|
in utero embryonic development
|
1.42
|
1.12e-12
|
GO:0065009
|
regulation of molecular function
|
2.26
|
1.26e-11
|
GO:0060562
|
epithelial tube morphogenesis
|
1.56
|
1.43e-11
|
GO:0016310
|
phosphorylation
|
1.50
|
1.57e-11
|
GO:0051641
|
cellular localization
|
1.95
|
1.91e-11
|
GO:0001568
|
blood vessel development
|
1.70
|
2.15e-11
|
GO:0051094
|
positive regulation of developmental process
|
1.40
|
3.41e-11
|
GO:0051239
|
regulation of multicellular organismal process
|
1.82
|
3.60e-11
|
GO:0009968
|
negative regulation of signal transduction
|
1.57
|
4.13e-11
|
GO:0031399
|
regulation of protein modification process
|
1.95
|
7.11e-11
|
GO:0048568
|
embryonic organ development
|
1.82
|
8.24e-11
|
GO:0007389
|
pattern specification process
|
1.59
|
1.00e-10
|
GO:0006468
|
protein phosphorylation
|
2.13
|
1.27e-10
|
GO:0032582
|
negative regulation of gene-specific transcription
|
1.72
|
1.30e-10
|
GO:0043069
|
negative regulation of programmed cell death
|
1.54
|
1.34e-10
|
GO:0022008
|
neurogenesis
|
1.71
|
1.59e-10
|
GO:0009967
|
positive regulation of signal transduction
|
1.73
|
1.64e-10
|
GO:0043066
|
negative regulation of apoptosis
|
1.89
|
1.67e-10
|
GO:0045596
|
negative regulation of cell differentiation
|
2.06
|
2.00e-10
|
GO:0048732
|
gland development
|
1.67
|
2.36e-10
|
GO:0008284
|
positive regulation of cell proliferation
|
1.46
|
2.73e-10
|
GO:0035556
|
intracellular signal transduction
|
1.43
|
3.75e-10
|
GO:0050790
|
regulation of catalytic activity
|
1.69
|
3.80e-10
|
GO:0060548
|
negative regulation of cell death
|
1.47
|
4.01e-10
|
GO:0008104
|
protein localization
|
1.60
|
4.02e-10
|
GO:0042325
|
regulation of phosphorylation
|
1.54
|
4.39e-10
|
GO:0044093
|
positive regulation of molecular function
|
1.54
|
4.59e-10
|
GO:0048699
|
generation of neurons
|
1.59
|
4.77e-10
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.59
|
4.77e-10
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.75
|
5.19e-10
|
GO:0010648
|
negative regulation of cell communication
|
1.52
|
5.59e-10
|
GO:0051128
|
regulation of cellular component organization
|
1.60
|
7.01e-10
|
GO:0012501
|
programmed cell death
|
1.83
|
8.95e-10
|
GO:0051301
|
cell division
|
1.27
|
1.03e-09
|
GO:0051234
|
establishment of localization
|
1.95
|
1.06e-09
|
GO:0061061
|
muscle structure development
|
1.73
|
2.06e-09
|
GO:0023057
|
negative regulation of signaling
|
1.96
|
2.90e-09
|
GO:0048514
|
blood vessel morphogenesis
|
1.89
|
3.01e-09
|
GO:0007507
|
heart development
|
1.94
|
3.35e-09
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.78
|
4.37e-09
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.59
|
5.07e-09
|
GO:0046907
|
intracellular transport
|
1.58
|
5.27e-09
|
GO:0006915
|
apoptosis
|
1.60
|
5.50e-09
|
GO:0001932
|
regulation of protein phosphorylation
|
1.80
|
5.69e-09
|
GO:0048534
|
hemopoietic or lymphoid organ development
|
1.98
|
5.76e-09
|
GO:0043193
|
positive regulation of gene-specific transcription
|
1.26
|
6.38e-09
|
GO:0006810
|
transport
|
1.54
|
6.44e-09
|
GO:0016265
|
death
|
1.80
|
7.04e-09
|
GO:0016568
|
chromatin modification
|
1.57
|
8.73e-09
|
GO:0043085
|
positive regulation of catalytic activity
|
1.74
|
9.18e-09
|
GO:0051093
|
negative regulation of developmental process
|
1.72
|
1.14e-08
|
GO:0043549
|
regulation of kinase activity
|
1.54
|
1.31e-08
|
GO:0008219
|
cell death
|
1.62
|
1.39e-08
|
GO:0023056
|
positive regulation of signaling
|
1.87
|
1.46e-08
|
GO:0001501
|
skeletal system development
|
2.25
|
2.00e-08
|
GO:0061138
|
morphogenesis of a branching epithelium
|
1.71
|
2.00e-08
|
GO:0045597
|
positive regulation of cell differentiation
|
1.62
|
2.24e-08
|
GO:0010942
|
positive regulation of cell death
|
2.34
|
2.63e-08
|
GO:0090092
|
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
2.15
|
2.79e-08
|
GO:0001763
|
morphogenesis of a branching structure
|
1.75
|
2.86e-08
|
GO:0002520
|
immune system development
|
1.61
|
3.12e-08
|
GO:0010647
|
positive regulation of cell communication
|
1.47
|
3.31e-08
|
GO:0051649
|
establishment of localization in cell
|
2.11
|
3.80e-08
|
GO:0010553
|
negative regulation of gene-specific transcription from RNA polymerase II promoter
|
1.62
|
4.45e-08
|
GO:0043068
|
positive regulation of programmed cell death
|
1.72
|
4.52e-08
|
GO:0045859
|
regulation of protein kinase activity
|
2.06
|
4.54e-08
|
GO:0001525
|
angiogenesis
|
1.68
|
4.54e-08
|
GO:0051338
|
regulation of transferase activity
|
1.62
|
4.76e-08
|
GO:0051276
|
chromosome organization
|
1.63
|
6.31e-08
|
GO:0032989
|
cellular component morphogenesis
|
1.62
|
6.51e-08
|
GO:0048585
|
negative regulation of response to stimulus
|
1.62
|
7.79e-08
|
GO:0030030
|
cell projection organization
|
2.19
|
1.02e-07
|
GO:0006417
|
regulation of translation
|
1.48
|
1.03e-07
|
GO:0048584
|
positive regulation of response to stimulus
|
2.03
|
1.26e-07
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
1.62
|
1.44e-07
|
GO:0071310
|
cellular response to organic substance
|
1.71
|
1.58e-07
|
GO:0008285
|
negative regulation of cell proliferation
|
1.61
|
1.66e-07
|
GO:0043065
|
positive regulation of apoptosis
|
2.02
|
1.75e-07
|
GO:0007346
|
regulation of mitotic cell cycle
|
2.23
|
2.35e-07
|
GO:0048754
|
branching morphogenesis of a tube
|
1.69
|
2.64e-07
|
GO:0006325
|
chromatin organization
|
1.63
|
3.58e-07
|
GO:0007417
|
central nervous system development
|
1.66
|
3.65e-07
|
GO:0060284
|
regulation of cell development
|
1.67
|
4.41e-07
|
GO:0000278
|
mitotic cell cycle
|
1.63
|
4.57e-07
|
GO:0000902
|
cell morphogenesis
|
1.75
|
4.99e-07
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
1.81
|
6.02e-07
|
GO:0003002
|
regionalization
|
1.77
|
6.15e-07
|
GO:0033043
|
regulation of organelle organization
|
2.39
|
9.60e-07
|
GO:0022612
|
gland morphogenesis
|
1.55
|
1.20e-06
|
GO:0030182
|
neuron differentiation
|
1.30
|
1.47e-06
|
GO:0044281
|
small molecule metabolic process
|
1.29
|
1.57e-06
|
GO:0065008
|
regulation of biological quality
|
1.61
|
1.72e-06
|
GO:0051247
|
positive regulation of protein metabolic process
|
1.71
|
1.73e-06
|
GO:0008283
|
cell proliferation
|
1.72
|
1.75e-06
|
GO:0051270
|
regulation of cellular component movement
|
1.44
|
1.78e-06
|
GO:0045184
|
establishment of protein localization
|
2.14
|
2.52e-06
|
GO:0030111
|
regulation of Wnt receptor signaling pathway
|
2.67
|
3.04e-06
|
GO:0060070
|
canonical Wnt receptor signaling pathway
|
1.61
|
3.20e-06
|
GO:0061024
|
membrane organization
|
1.62
|
3.59e-06
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
1.61
|
3.84e-06
|
GO:0009719
|
response to endogenous stimulus
|
2.25
|
4.09e-06
|
GO:0016331
|
morphogenesis of embryonic epithelium
|
1.60
|
4.36e-06
|
GO:0016044
|
cellular membrane organization
|
1.85
|
4.65e-06
|
GO:0071900
|
regulation of protein serine/threonine kinase activity
|
1.51
|
4.70e-06
|
GO:0022402
|
cell cycle process
|
2.02
|
5.20e-06
|
GO:0001655
|
urogenital system development
|
1.84
|
6.07e-06
|
GO:0010564
|
regulation of cell cycle process
|
1.91
|
6.14e-06
|
GO:0009952
|
anterior/posterior pattern formation
|
1.66
|
6.64e-06
|
GO:0007243
|
intracellular protein kinase cascade
|
1.66
|
6.64e-06
|
GO:0023014
|
signal transduction via phosphorylation event
|
1.43
|
7.06e-06
|
GO:0015031
|
protein transport
|
2.29
|
9.01e-06
|
GO:0030879
|
mammary gland development
|
1.66
|
9.18e-06
|
GO:0051130
|
positive regulation of cellular component organization
|
1.49
|
9.22e-06
|
GO:0040011
|
locomotion
|
1.94
|
9.33e-06
|
GO:0045165
|
cell fate commitment
|
1.95
|
1.01e-05
|
GO:0016055
|
Wnt receptor signaling pathway
|
1.66
|
1.04e-05
|
GO:0007420
|
brain development
|
2.37
|
1.21e-05
|
GO:0060485
|
mesenchyme development
|
2.29
|
1.36e-05
|
GO:2000027
|
regulation of organ morphogenesis
|
1.48
|
1.76e-05
|
GO:0016192
|
vesicle-mediated transport
|
1.97
|
1.87e-05
|
GO:0008544
|
epidermis development
|
2.56
|
2.58e-05
|
GO:0001942
|
hair follicle development
|
2.56
|
2.58e-05
|
GO:0022404
|
molting cycle process
|
2.56
|
2.58e-05
|
GO:0022405
|
hair cycle process
|
1.69
|
2.61e-05
|
GO:0030097
|
hemopoiesis
|
2.52
|
2.96e-05
|
GO:0001892
|
embryonic placenta development
|
2.15
|
3.02e-05
|
GO:0021915
|
neural tube development
|
3.12
|
3.03e-05
|
GO:0048286
|
lung alveolus development
|
1.60
|
3.12e-05
|
GO:0010627
|
regulation of intracellular protein kinase cascade
|
1.32
|
3.40e-05
|
GO:0009056
|
catabolic process
|
2.85
|
3.48e-05
|
GO:0061180
|
mammary gland epithelium development
|
1.91
|
3.61e-05
|
GO:0051493
|
regulation of cytoskeleton organization
|
1.64
|
4.23e-05
|
GO:0031175
|
neuron projection development
|
2.29
|
4.69e-05
|
GO:0035148
|
tube formation
|
1.56
|
4.71e-05
|
GO:0022403
|
cell cycle phase
|
1.60
|
4.79e-05
|
GO:0009725
|
response to hormone stimulus
|
2.48
|
4.99e-05
|
GO:0042303
|
molting cycle
|
2.48
|
4.99e-05
|
GO:0042633
|
hair cycle
|
2.06
|
5.31e-05
|
GO:0048736
|
appendage development
|
2.06
|
5.31e-05
|
GO:0060173
|
limb development
|
1.55
|
6.11e-05
|
GO:0006928
|
cellular component movement
|
1.54
|
6.12e-05
|
GO:0034613
|
cellular protein localization
|
1.60
|
6.13e-05
|
GO:0051960
|
regulation of nervous system development
|
2.37
|
6.32e-05
|
GO:0055123
|
digestive system development
|
1.93
|
7.42e-05
|
GO:0048705
|
skeletal system morphogenesis
|
1.35
|
7.48e-05
|
GO:0032879
|
regulation of localization
|
1.63
|
8.00e-05
|
GO:0003006
|
developmental process involved in reproduction
|
1.63
|
8.00e-05
|
GO:0040012
|
regulation of locomotion
|
1.83
|
8.94e-05
|
GO:0048562
|
embryonic organ morphogenesis
|
1.62
|
9.25e-05
|
GO:0050767
|
regulation of neurogenesis
|
1.53
|
9.96e-05
|
GO:0070727
|
cellular macromolecule localization
|
1.58
|
1.05e-04
|
GO:0016477
|
cell migration
|
1.90
|
1.12e-04
|
GO:0007517
|
muscle organ development
|
2.05
|
1.18e-04
|
GO:0035107
|
appendage morphogenesis
|
2.05
|
1.18e-04
|
GO:0035108
|
limb morphogenesis
|
1.91
|
1.33e-04
|
GO:0045786
|
negative regulation of cell cycle
|
1.61
|
1.44e-04
|
GO:0031401
|
positive regulation of protein modification process
|
2.21
|
1.65e-04
|
GO:0045787
|
positive regulation of cell cycle
|
2.21
|
1.65e-04
|
GO:0060828
|
regulation of canonical Wnt receptor signaling pathway
|
1.66
|
1.66e-04
|
GO:0018193
|
peptidyl-amino acid modification
|
1.54
|
1.71e-04
|
GO:0048666
|
neuron development
|
1.43
|
1.79e-04
|
GO:0070887
|
cellular response to chemical stimulus
|
1.65
|
1.80e-04
|
GO:0030334
|
regulation of cell migration
|
1.59
|
1.97e-04
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
2.41
|
2.05e-04
|
GO:0045667
|
regulation of osteoblast differentiation
|
1.85
|
2.12e-04
|
GO:0048608
|
reproductive structure development
|
1.67
|
2.18e-04
|
GO:0040007
|
growth
|
1.33
|
2.37e-04
|
GO:0044248
|
cellular catabolic process
|
1.69
|
2.58e-04
|
GO:0048812
|
neuron projection morphogenesis
|
1.74
|
2.68e-04
|
GO:0010562
|
positive regulation of phosphorus metabolic process
|
1.74
|
2.68e-04
|
GO:0045937
|
positive regulation of phosphate metabolic process
|
2.05
|
2.75e-04
|
GO:0033673
|
negative regulation of kinase activity
|
1.80
|
2.77e-04
|
GO:0016569
|
covalent chromatin modification
|
1.53
|
2.80e-04
|
GO:0048870
|
cell motility
|
1.53
|
2.80e-04
|
GO:0051674
|
localization of cell
|
1.56
|
3.08e-04
|
GO:0044262
|
cellular carbohydrate metabolic process
|
1.60
|
3.42e-04
|
GO:0032535
|
regulation of cellular component size
|
1.64
|
3.70e-04
|
GO:0012502
|
induction of programmed cell death
|
1.74
|
3.77e-04
|
GO:0071495
|
cellular response to endogenous stimulus
|
1.63
|
3.99e-04
|
GO:2000145
|
regulation of cell motility
|
1.73
|
4.24e-04
|
GO:0042327
|
positive regulation of phosphorylation
|
1.36
|
4.38e-04
|
GO:0022607
|
cellular component assembly
|
2.91
|
4.44e-04
|
GO:0061035
|
regulation of cartilage development
|
1.65
|
4.92e-04
|
GO:0007264
|
small GTPase mediated signal transduction
|
1.85
|
5.39e-04
|
GO:0030855
|
epithelial cell differentiation
|
2.28
|
5.59e-04
|
GO:0048660
|
regulation of smooth muscle cell proliferation
|
1.68
|
5.63e-04
|
GO:0051101
|
regulation of DNA binding
|
1.60
|
5.94e-04
|
GO:0051098
|
regulation of binding
|
1.63
|
6.17e-04
|
GO:0006917
|
induction of apoptosis
|
2.06
|
6.43e-04
|
GO:0006469
|
negative regulation of protein kinase activity
|
2.63
|
6.58e-04
|
GO:0090100
|
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
2.07
|
6.77e-04
|
GO:0030326
|
embryonic limb morphogenesis
|
2.07
|
6.77e-04
|
GO:0035113
|
embryonic appendage morphogenesis
|
1.79
|
7.00e-04
|
GO:0051272
|
positive regulation of cellular component movement
|
1.78
|
7.22e-04
|
GO:0016570
|
histone modification
|
1.57
|
7.31e-04
|
GO:0007423
|
sensory organ development
|
1.54
|
7.51e-04
|
GO:0090066
|
regulation of anatomical structure size
|
2.38
|
7.59e-04
|
GO:0048863
|
stem cell differentiation
|
2.20
|
8.51e-04
|
GO:0001838
|
embryonic epithelial tube formation
|
2.20
|
8.51e-04
|
GO:0072175
|
epithelial tube formation
|
1.88
|
8.72e-04
|
GO:0048589
|
developmental growth
|
2.83
|
8.98e-04
|
GO:0035567
|
non-canonical Wnt receptor signaling pathway
|
1.86
|
1.04e-03
|
GO:0042692
|
muscle cell differentiation
|
1.59
|
1.09e-03
|
GO:0030163
|
protein catabolic process
|
2.25
|
1.29e-03
|
GO:0048762
|
mesenchymal cell differentiation
|
1.40
|
1.32e-03
|
GO:0033554
|
cellular response to stress
|
2.52
|
1.34e-03
|
GO:0061008
|
hepaticobiliary system development
|
2.66
|
1.47e-03
|
GO:0060443
|
mammary gland morphogenesis
|
1.62
|
1.48e-03
|
GO:0051347
|
positive regulation of transferase activity
|
1.64
|
1.51e-03
|
GO:0010740
|
positive regulation of intracellular protein kinase cascade
|
2.38
|
1.74e-03
|
GO:0001657
|
ureteric bud development
|
1.68
|
1.75e-03
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.63
|
1.76e-03
|
GO:0033674
|
positive regulation of kinase activity
|
1.46
|
1.81e-03
|
GO:0005975
|
carbohydrate metabolic process
|
1.57
|
2.10e-03
|
GO:0032990
|
cell part morphogenesis
|
2.47
|
2.26e-03
|
GO:0048864
|
stem cell development
|
1.64
|
2.35e-03
|
GO:0045860
|
positive regulation of protein kinase activity
|
1.98
|
2.41e-03
|
GO:0030278
|
regulation of ossification
|
1.31
|
2.56e-03
|
GO:0044085
|
cellular component biogenesis
|
1.77
|
2.89e-03
|
GO:0030335
|
positive regulation of cell migration
|
1.77
|
2.89e-03
|
GO:2000147
|
positive regulation of cell motility
|
1.47
|
2.92e-03
|
GO:0007010
|
cytoskeleton organization
|
1.61
|
3.11e-03
|
GO:0006511
|
ubiquitin-dependent protein catabolic process
|
1.59
|
3.30e-03
|
GO:0051603
|
proteolysis involved in cellular protein catabolic process
|
2.05
|
3.34e-03
|
GO:0048706
|
embryonic skeletal system development
|
2.48
|
3.42e-03
|
GO:0001889
|
liver development
|
1.92
|
3.49e-03
|
GO:0051348
|
negative regulation of transferase activity
|
1.67
|
3.80e-03
|
GO:0000280
|
nuclear division
|
1.67
|
3.80e-03
|
GO:0007067
|
mitosis
|
1.80
|
3.88e-03
|
GO:0050678
|
regulation of epithelial cell proliferation
|
2.38
|
4.00e-03
|
GO:0042476
|
odontogenesis
|
2.14
|
4.19e-03
|
GO:0030178
|
negative regulation of Wnt receptor signaling pathway
|
2.34
|
4.21e-03
|
GO:0014020
|
primary neural tube formation
|
2.30
|
4.35e-03
|
GO:0009798
|
axis specification
|
1.68
|
4.41e-03
|
GO:0043408
|
regulation of MAPKKK cascade
|
2.27
|
4.43e-03
|
GO:0048565
|
digestive tract development
|
1.66
|
4.67e-03
|
GO:0090046
|
regulation of transcription regulator activity
|
1.59
|
4.78e-03
|
GO:0019941
|
modification-dependent protein catabolic process
|
1.65
|
5.07e-03
|
GO:0000087
|
M phase of mitotic cell cycle
|
1.56
|
5.11e-03
|
GO:0048858
|
cell projection morphogenesis
|
2.48
|
5.18e-03
|
GO:0019827
|
stem cell maintenance
|
1.98
|
5.65e-03
|
GO:0031346
|
positive regulation of cell projection organization
|
1.93
|
6.06e-03
|
GO:0072001
|
renal system development
|
2.34
|
6.38e-03
|
GO:0060606
|
tube closure
|
1.94
|
6.59e-03
|
GO:0001822
|
kidney development
|
1.58
|
6.84e-03
|
GO:0043632
|
modification-dependent macromolecule catabolic process
|
1.43
|
7.73e-03
|
GO:0006259
|
DNA metabolic process
|
3.06
|
7.86e-03
|
GO:0048538
|
thymus development
|
1.56
|
7.98e-03
|
GO:0044257
|
cellular protein catabolic process
|
2.87
|
8.10e-03
|
GO:0060603
|
mammary gland duct morphogenesis
|
1.72
|
8.23e-03
|
GO:0040017
|
positive regulation of locomotion
|
1.92
|
8.88e-03
|
GO:0007178
|
transmembrane receptor protein serine/threonine kinase signaling pathway
|
3.58
|
9.03e-03
|
GO:0009950
|
dorsal/ventral axis specification
|
2.38
|
9.22e-03
|
GO:0000082
|
G1/S transition of mitotic cell cycle
|
2.13
|
9.45e-03
|
GO:0050657
|
nucleic acid transport
|
2.13
|
9.45e-03
|
GO:0050658
|
RNA transport
|
2.13
|
9.45e-03
|
GO:0051236
|
establishment of RNA localization
|
1.93
|
9.67e-03
|
GO:0043281
|
regulation of caspase activity
|
2.15
|
9.75e-03
|
GO:0048704
|
embryonic skeletal system morphogenesis
|
1.68
|
9.88e-03
|
GO:0032870
|
cellular response to hormone stimulus
|
1.42
|
9.91e-03
|
GO:0009057
|
macromolecule catabolic process
|
2.18
|
9.99e-03
|
GO:0001841
|
neural tube formation
|
2.01
|
1.03e-02
|
GO:0007369
|
gastrulation
|
1.64
|
1.09e-02
|
GO:0007409
|
axonogenesis
|
1.80
|
1.09e-02
|
GO:0051169
|
nuclear transport
|
1.62
|
1.12e-02
|
GO:0048285
|
organelle fission
|
1.95
|
1.14e-02
|
GO:0051325
|
interphase
|
1.21
|
1.15e-02
|
GO:0042221
|
response to chemical stimulus
|
1.83
|
1.16e-02
|
GO:0001503
|
ossification
|
1.81
|
1.22e-02
|
GO:0006913
|
nucleocytoplasmic transport
|
1.97
|
1.23e-02
|
GO:0046822
|
regulation of nucleocytoplasmic transport
|
1.97
|
1.23e-02
|
GO:0051329
|
interphase of mitotic cell cycle
|
2.06
|
1.24e-02
|
GO:0042306
|
regulation of protein import into nucleus
|
1.45
|
1.34e-02
|
GO:0044265
|
cellular macromolecule catabolic process
|
1.81
|
1.35e-02
|
GO:0010720
|
positive regulation of cell development
|
1.99
|
1.43e-02
|
GO:0001890
|
placenta development
|
1.63
|
1.50e-02
|
GO:0051090
|
regulation of sequence-specific DNA binding transcription factor activity
|
2.17
|
1.51e-02
|
GO:0071901
|
negative regulation of protein serine/threonine kinase activity
|
1.45
|
1.51e-02
|
GO:0040008
|
regulation of growth
|
2.30
|
1.52e-02
|
GO:0001843
|
neural tube closure
|
2.01
|
1.53e-02
|
GO:0015931
|
nucleobase, nucleoside, nucleotide and nucleic acid transport
|
2.23
|
1.55e-02
|
GO:0017015
|
regulation of transforming growth factor beta receptor signaling pathway
|
1.70
|
1.62e-02
|
GO:0007548
|
sex differentiation
|
2.50
|
1.80e-02
|
GO:0042475
|
odontogenesis of dentine-containing tooth
|
1.63
|
1.82e-02
|
GO:0030900
|
forebrain development
|
1.59
|
1.85e-02
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
2.07
|
1.95e-02
|
GO:0009953
|
dorsal/ventral pattern formation
|
1.84
|
2.05e-02
|
GO:0010638
|
positive regulation of organelle organization
|
1.72
|
2.07e-02
|
GO:0060537
|
muscle tissue development
|
1.58
|
2.07e-02
|
GO:0008361
|
regulation of cell size
|
4.68
|
2.07e-02
|
GO:0003170
|
heart valve development
|
2.12
|
2.13e-02
|
GO:0051147
|
regulation of muscle cell differentiation
|
1.38
|
2.28e-02
|
GO:0071844
|
cellular component assembly at cellular level
|
1.61
|
2.36e-02
|
GO:0006897
|
endocytosis
|
1.61
|
2.36e-02
|
GO:0010324
|
membrane invagination
|
1.50
|
2.37e-02
|
GO:0009894
|
regulation of catabolic process
|
1.85
|
2.50e-02
|
GO:0032386
|
regulation of intracellular transport
|
2.51
|
2.73e-02
|
GO:0001658
|
branching involved in ureteric bud morphogenesis
|
2.05
|
2.76e-02
|
GO:0006403
|
RNA localization
|
1.78
|
3.19e-02
|
GO:0043523
|
regulation of neuron apoptosis
|
1.55
|
3.25e-02
|
GO:0032446
|
protein modification by small protein conjugation
|
1.92
|
3.32e-02
|
GO:0033157
|
regulation of intracellular protein transport
|
1.48
|
3.48e-02
|
GO:0000279
|
M phase
|
2.19
|
3.50e-02
|
GO:0090101
|
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
1.64
|
3.51e-02
|
GO:0001934
|
positive regulation of protein phosphorylation
|
1.26
|
3.51e-02
|
GO:0010033
|
response to organic substance
|
2.60
|
3.61e-02
|
GO:0045669
|
positive regulation of osteoblast differentiation
|
1.81
|
3.82e-02
|
GO:0003007
|
heart morphogenesis
|
2.52
|
4.14e-02
|
GO:0035272
|
exocrine system development
|
1.95
|
4.27e-02
|
GO:0035270
|
endocrine system development
|
1.32
|
4.33e-02
|
GO:0000003
|
reproduction
|
2.06
|
4.36e-02
|
GO:0043524
|
negative regulation of neuron apoptosis
|
2.72
|
4.49e-02
|
GO:0045931
|
positive regulation of mitotic cell cycle
|
2.10
|
4.81e-02
|
GO:0051028
|
mRNA transport
|
1.32
|
4.81e-02
|
GO:0022414
|
reproductive process
|
2.39
|
4.92e-02
|
GO:0060675
|
ureteric bud morphogenesis
|